Wiley Bros. Aintree Capital, LLC Lantheus Holdings, Inc. Transaction History
Wiley Bros. Aintree Capital, LLC
- $8.04 Billion
- Q4 2024
A detailed history of Wiley Bros. Aintree Capital, LLC transactions in Lantheus Holdings, Inc. stock. As of the latest transaction made, Wiley Bros. Aintree Capital, LLC holds 11,778 shares of LNTH stock, worth $1.1 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
11,778
Previous 7,239
62.7%
Holding current value
$1.1 Million
Previous $794,000
32.62%
% of portfolio
0.01%
Previous 0.02%
Shares
3 transactions
Others Institutions Holding LNTH
# of Institutions
532Shares Held
73MCall Options Held
598KPut Options Held
371K-
Black Rock Inc. New York, NY8.6MShares$802 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.24MShares$675 Million0.01% of portfolio
-
Janus Henderson Group PLC London, X06.2MShares$578 Million0.29% of portfolio
-
Farallon Capital Management LLC San Francisco, CA5.32MShares$496 Million2.53% of portfolio
-
State Street Corp Boston, MA2.64MShares$246 Million0.01% of portfolio
About Lantheus Holdings, Inc.
- Ticker LNTH
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 68,741,904
- Market Cap $6.41B
- Description
- Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide. It provides DEFINITY, a microbubble ultrasound enhancing agent used in ultrasound exams of the heart; TechneLite, a technetium generator for n...